abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Эта страница недоступна на Русский и отображается на English

Статья

25 Окт 2001

Автор:
Stop Patient Abuse Now [SPAN]

Cipro Deal Puts Industry Profits Ahead of Public Health - Consumers Question Pharmaceutical Industry Influence at HHS [U.S. Department of Health & Human Services] and FDA [U.S. Food & Drug Administration]

The German-based Bayer corporation has prevailed upon the Department of Health and Human Services to put its interests before the safety of U.S. citizens in the Cipro deal struck this week by Secretary Tommy Thompson, according to the SPAN Coalition.